Inactive Instrument

News Scibase AB Swiss Exchange

Stocks

SE0007045414

Advanced Medical Equipment & Technology

End-of-day quote Swiss Exchange Other stock markets
- ^SEK	-

03-02	SciBase Wins US FDA Nod for Skin Cancer Detection Device Label Expansion	MT
11-07	SciBase, Castle Biosciences Expand License Deal, Secures SEK20 Million Loan	MT

All News

Mentions Relevance

05-28	SciBase announces that the board of directors has resolved on the record date for the reverse share split	AQ
05-28	Nevisense detects skin barrier damage by chemicals used in household cleaning products in a new ex-vivo study	AQ
05-19	Bulletin from the annual general meeting in SciBase Holding AB (publ)	AQ
05-18	Scibase : Presentation proposed board of directors	PU
05-18	SciBase Announces New Research Highlighting Nevisense's Potential in Detecting Age-Related Skin Barrier Changes	AQ
05-13	SciBase (Q1 Review): Progress across key growth drivers	AQ
05-07	Interim report	AQ
04-27	Scibase : Annual report 2025 Press Release	PU
04-27	Scibase : Annual report 2025 Report	PU
04-27	SciBase publishes the Annual report for 2025	AQ
04-14	Notice to attend the annual general meeting in Scibase Holding AB (publ)	AQ
04-07	SciBase : reaches milestone with over 400,000 tests sold with Nevisense	PU
03-16	SciBase (Q4 Review): Strong growth, key catalysts ahead	AQ
03-13	Interim report	AQ
03-10	New Study Positions Nevisense's EIS as a valuable and sensitive tool for assessing skin barrier impairment	AQ
03-05	New Publication: US clinicians' real-world Nevisense experience improves melanoma detection	AQ
03-02	SciBase Wins US FDA Nod for Skin Cancer Detection Device Label Expansion	MT
03-02	SciBase receives approval by FDA for extended labelling in the US	AQ
02-19	SciBase's Nevisense (EIS) Included in the US NCCN Guidelines for Melanoma which supports the use of EIS in the detection of melanoma	AQ
02-17	A new study demonstrates that Nevisense can predict atopic dermatitis in Newborns	AQ
02-06	Recalculation of warrants of series TO 2 following rights issue and updated last day of trading in BTA from the rights issue	AQ
01-27	SciBase announces final outcome of the rights issue and the resolution on a set-off issue within the framework of the offer to repurchase outstanding warrants of series TO 2	AQ
01-26	Change of date for publication of the year-end report for the financial year 2025	AQ
01-22	Increased commitment in SciBase rights issue	AQ
01-12	SciBase announces outcome of the offer to repurchase outstanding warrants of series to 2	AQ